Individuals with Alzheimer disease (AD) initiating antipsychotics have an increased risk for head injuries and traumatic brain injury.
Taro Pharmaceuticals announced the voluntary recall of 1 lot of lamotrigine 100mg tablets to the consumer level due to cross-contamination with a small amount of enalapril maleate.
In July 2017, Eagle had received a Complete Response Letter (CRL) from the FDA stating that an additional clinical trial would be needed prior to approval for the indication.
The FDA has granted Fast Track designation to AXER-204 (ReNetX Bio) for the potential treatment of chronic spinal cord injury.
Cardiorespiratory fitness (CRF) is positively associated with gray matter (GM) volume and total brain volume and with GM volume in specific brain areas.
Frailty is an important predictor of worse outcome after traumatic spinal cord injury (tSCI) in patients <75 years of age.
Researchers assessed the diagnostic value of clinical factors as well as biochemical or microbiologic measures for diagnosis of drain-associated ventriculitis.
Prescription pain and sleep drug use is significantly associated with an increased incidence of frailty.
The Science of Cannabis Symposium welcomed both clinicians and legal experts and aimed to provide medical and legal education for healthcare providers who are considering the use of cannabis in their medical practice.
The clinical approach to management of Cushing disease is often complex and education on a clear approach is paramount.